These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 30534426)
1. Immunoexpression of N-cadherin, Twist and Vimentin in Bladder Urothelial Carcinomas. Stepan AE; Ciucă M; Simionescu C; Stepan D; Mărgăritescu C Curr Health Sci J; 2015; 41(3):219-226. PubMed ID: 30534426 [TBL] [Abstract][Full Text] [Related]
2. The cadherin switch assessment in the epithelial-mesenchymal transition of urothelial bladder carcinomas. Drocaş AI; Tomescu PI; Mitroi G; Drăgoescu PO; Mărgăritescu C; Stepan AE; Şurlin V; CrăiŢoiu Ş; Drocaş I; Ungureanu AM; Găman AE; Turculeanu A; Simionescu CE Rom J Morphol Embryol; 2016; 57(3):1037-1044. PubMed ID: 28002521 [TBL] [Abstract][Full Text] [Related]
3. Epithelial mesenchymal transition in urothelial carcinoma: twist in the tale. Paliwal P; Arora D; Mishra AK Indian J Pathol Microbiol; 2012; 55(4):443-9. PubMed ID: 23455777 [TBL] [Abstract][Full Text] [Related]
4. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases. Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229 [TBL] [Abstract][Full Text] [Related]
5. E-cadherin÷CD44 immunophenotype in the epithelial-mesenchymal transition of bladder urothelial carcinomas. Stepan AE; Pirici D; Bălăşoiu M; Novac MB; Drocaş AI; Ciurea RN; Stepan D; Gheonea DI; Simionescu CE Rom J Morphol Embryol; 2015; 56(1):85-91. PubMed ID: 25826491 [TBL] [Abstract][Full Text] [Related]
6. Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: correlation with intravesical recurrence following transurethral resection. Liu B; Miyake H; Nishikawa M; Fujisawa M Urol Oncol; 2015 Mar; 33(3):110.e11-8. PubMed ID: 25262382 [TBL] [Abstract][Full Text] [Related]
7. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder. Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the epithelial-to-mesenchymal transition markers e-cadherin, vimentin and twist in bladder cancer. Zhao J; Dong D; Sun L; Zhang G; Sun L Int Braz J Urol; 2014; 40(2):179-89. PubMed ID: 24856504 [TBL] [Abstract][Full Text] [Related]
9. Positive Correlation between Matrix Metalloproteinases and Epithelial-to-Mesenchymal Transition and its Association with Clinical Outcome in Bladder Cancer Patients. Singh R; Mandhani A; Agrawal V; Garg M Cancer Microenviron; 2018 Jun; 11(1):23-39. PubMed ID: 29349669 [TBL] [Abstract][Full Text] [Related]
10. Relationship between TWIST expression and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma. Gao Y; Xuan XY; Zhang HY; Wang F; Zeng QR; Wang ZQ; Li SS Cell Biol Int; 2012 Jun; 36(6):571-7. PubMed ID: 22360285 [TBL] [Abstract][Full Text] [Related]
14. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells. Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207 [TBL] [Abstract][Full Text] [Related]
15. Loss of E-cadherin expression in recurrent non-invasive urothelial carcinoma of the bladder. Balci MG; Tayfur M Int J Clin Exp Pathol; 2018; 11(8):4163-4168. PubMed ID: 31949810 [TBL] [Abstract][Full Text] [Related]
16. The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors. Bozhkova DM; Poryazova-Markova EG Folia Med (Plovdiv); 2019 Jun; 61(2):296-302. PubMed ID: 31301662 [TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of hypoxia-inducible factor 1α, TWIST and E-cadherin is associated with aggressive tumor phenotypes in endometrioid endometrial carcinoma. Feng Z; Gan H; Cai Z; Li N; Yang Z; Lu G; Chen J Jpn J Clin Oncol; 2013 Apr; 43(4):396-403. PubMed ID: 23372184 [TBL] [Abstract][Full Text] [Related]
18. Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial-mesenchymal transition-related proteins. Liu PF; Kang BH; Wu YM; Sun JH; Yen LM; Fu TY; Lin YC; Liou HH; Lin YS; Sie HC; Hsieh IC; Tseng YK; Shu CW; Hsieh YD; Ger LP PLoS One; 2017; 12(6):e0178581. PubMed ID: 28570699 [TBL] [Abstract][Full Text] [Related]
19. Low-grade metastases in high-grade clear cell renal cell carcinomas: A clinicopathologic study of 4 cases with an insight into the role of mesenchymal-to-epithelial transition process. López JI; Mosteiro L; Guarch R; Larrinaga G; Pulido R; Angulo JC Ann Diagn Pathol; 2016 Feb; 20():13-8. PubMed ID: 26616721 [TBL] [Abstract][Full Text] [Related]
20. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition. Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]